应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02181 迈博药业-B
未开盘 05-06 16:08:33
0.430
+0.000
0.00%
最高
0.430
最低
0.430
成交量
1.40万
今开
0.430
昨收
0.430
日振幅
0.00%
总市值
17.73亿
流通市值
17.73亿
总股本
41.24亿
成交额
6,020
换手率
0.00%
流通股本
41.24亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
迈博药业-B盘中异动 早盘急速下跌8.79%报0.415港元
市场透视 · 04-30
迈博药业-B盘中异动 早盘急速下跌8.79%报0.415港元
迈博药业-B盘中异动 快速跳水7.61%报0.425港元
市场透视 · 04-28
迈博药业-B盘中异动 快速跳水7.61%报0.425港元
迈博药业-B盘中异动 急速跳水6.25%报0.450港元
市场透视 · 04-23
迈博药业-B盘中异动 急速跳水6.25%报0.450港元
迈博药业-B盘中异动 快速下挫9.09%
市场透视 · 04-22
迈博药业-B盘中异动 快速下挫9.09%
迈博药业-B盘中异动 股价大跌5.21%报0.455港元
市场透视 · 04-15
迈博药业-B盘中异动 股价大跌5.21%报0.455港元
港股生物医药B类股逆势活跃,歌礼制药-B涨超8%
老虎资讯综合 · 04-15
港股生物医药B类股逆势活跃,歌礼制药-B涨超8%
迈博药业-B盘中异动 下午盘股价大跌9.43%报0.480港元
市场透视 · 03-11
迈博药业-B盘中异动 下午盘股价大跌9.43%报0.480港元
迈博药业-B股价重挫18.64% 市值跌3.69亿港元
市场透视 · 03-10
迈博药业-B股价重挫18.64% 市值跌3.69亿港元
迈博药业-B盘中异动 早盘急速上涨6.06%
市场透视 · 03-06
迈博药业-B盘中异动 早盘急速上涨6.06%
迈博药业-B股价飙升10.00% 市值涨1.36亿港元
市场透视 · 02-28
迈博药业-B股价飙升10.00% 市值涨1.36亿港元
迈博药业-B盘中异动 临近收盘急速拉升5.26%报0.300港元
市场透视 · 02-27
迈博药业-B盘中异动 临近收盘急速拉升5.26%报0.300港元
迈博药业-B盘中异动 下午盘股价大跌8.20%
市场透视 · 02-26
迈博药业-B盘中异动 下午盘股价大跌8.20%
迈博药业-B股价重挫21.62% 市值跌2.59亿港元
市场透视 · 02-20
迈博药业-B股价重挫21.62% 市值跌2.59亿港元
迈博药业-B盘中异动 下午盘快速跳水10.00%
市场透视 · 02-11
迈博药业-B盘中异动 下午盘快速跳水10.00%
迈博药业-B(02181)股价下跌10%,现价港币$0.27
阿斯达克财经 · 02-11
迈博药业-B(02181)股价下跌10%,现价港币$0.27
迈博药业-B盘中异动 早盘股价大跌5.66%
市场透视 · 01-13
迈博药业-B盘中异动 早盘股价大跌5.66%
迈博药业-B1月6日收盘上涨1.82%,成交4.62万港元
金融界 · 01-06
迈博药业-B1月6日收盘上涨1.82%,成交4.62万港元
迈博药业-B1月3日收盘下跌1.79%,成交4.07万港元
金融界 · 01-03
迈博药业-B1月3日收盘下跌1.79%,成交4.07万港元
迈博药业(02181.HK)核心产品CMAB008获巴基斯坦注册批准
阿斯达克财经 · 01-02
迈博药业(02181.HK)核心产品CMAB008获巴基斯坦注册批准
迈博药业-B(02181):巴基斯坦药品监管局批准核心产品CMAB008(注射用英夫利西单抗)的注册
智通财经 · 01-02
迈博药业-B(02181):巴基斯坦药品监管局批准核心产品CMAB008(注射用英夫利西单抗)的注册
加载更多
公司概况
公司名称:
迈博药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要产品包括奥马珠单抗(CMAB007)、西妥昔单抗(CMAB009)和英夫利昔单抗(CMAB008)等。该公司主要在中国境内经营业务。
发行价格:
--
{"stockData":{"symbol":"02181","market":"HK","secType":"STK","nameCN":"迈博药业-B","latestPrice":0.43,"timestamp":1746518913017,"preClose":0.43,"halted":0,"volume":14000,"delay":0,"floatShares":4124080000,"shares":4124080000,"eps":-0.03335737109814043,"marketStatus":"未开盘","change":0,"latestTime":"05-06 16:08:33","open":0.43,"high":0.43,"low":0.43,"amount":6020,"amplitude":0,"askPrice":0.455,"askSize":8000,"bidPrice":0.41,"bidSize":24000,"shortable":0,"etf":0,"ttmEps":-0.03335737109814043,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746581400000},"marketStatusCode":0,"adr":0,"listingDate":1559232000000,"exchange":"SEHK","adjPreClose":0.43,"openAndCloseTimeList":[[1746495000000,1746504000000],[1746507600000,1746518400000]],"volumeRatio":0.083933,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02181","defaultTab":"news","newsList":[{"id":"2531574069","title":"迈博药业-B盘中异动 早盘急速下跌8.79%报0.415港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531574069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531574069?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:50","pubTimestamp":1745977855,"startTime":"0","endTime":"0","summary":"2025年04月30日早盘09时50分,迈博药业-B股票出现波动,股价快速下挫8.79%。截至发稿,该股报0.415港元/股,成交量6000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出2490港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为2.27%。其相关个股中,乐普生物-B、百济神州、康希诺生物涨幅较大,振幅较大的相关个股有乐普生物-B、科伦博泰生物-B、百济神州,振幅分别为7.61%、5.54%、5.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430095056aa2c7ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430095056aa2c7ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"gpt_icon":0},{"id":"2530041711","title":"迈博药业-B盘中异动 快速跳水7.61%报0.425港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530041711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530041711?lang=zh_cn&edition=full","pubTime":"2025-04-28 13:16","pubTimestamp":1745817392,"startTime":"0","endTime":"0","summary":"2025年04月28日下午盘13时16分,迈博药业-B股票出现波动,股价快速下跌7.61%。截至发稿,该股报0.425港元/股,成交量5万股,换手率0.00%,振幅8.70%。资金方面,该股资金流入0港元,流出2.242万港元。迈博药业-B股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,君实生物、博安生物、创胜集团-B涨幅较大,振幅较大的相关个股有云康集团、君实生物、中国抗体-B,振幅分别为16.05%、13.75%、13.74%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504281316329748020f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504281316329748020f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"gpt_icon":0},{"id":"2529251813","title":"迈博药业-B盘中异动 急速跳水6.25%报0.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529251813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529251813?lang=zh_cn&edition=full","pubTime":"2025-04-23 10:14","pubTimestamp":1745374463,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘10时14分,迈博药业-B股票出现异动,股价大幅下挫6.25%。截至发稿,该股报0.450港元/股,成交量22万股,换手率0.01%,振幅2.08%。资金方面,该股资金流入0港元,流出9.978万港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为1.70%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504231014239741723a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504231014239741723a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161"],"gpt_icon":0},{"id":"2529236059","title":"迈博药业-B盘中异动 快速下挫9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529236059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529236059?lang=zh_cn&edition=full","pubTime":"2025-04-22 10:03","pubTimestamp":1745287381,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘10时03分,迈博药业-B股票出现波动,股价急速下挫9.09%。截至发稿,该股报0.450港元/股,成交量30万股,换手率0.01%,振幅9.09%。迈博药业-B股票所在的生物技术行业中,整体涨幅为2.94%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422100301a6c31d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422100301a6c31d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"gpt_icon":0},{"id":"2527410183","title":"迈博药业-B盘中异动 股价大跌5.21%报0.455港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527410183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527410183?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:22","pubTimestamp":1744683746,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘10时22分,迈博药业-B股票出现异动,股价快速下跌5.21%。截至发稿,该股报0.455港元/股,成交量11万股,换手率0.00%,振幅9.37%。资金方面,该股资金流入3000港元,流出4.813万港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.50%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415102226a6bab283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415102226a6bab283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"gpt_icon":0},{"id":"1194576384","title":"港股生物医药B类股逆势活跃,歌礼制药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194576384","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194576384?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:11","pubTimestamp":1744683073,"startTime":"0","endTime":"0","summary":"港股异动|生物医药B类股逆势活跃,$歌礼制药-B(01672)$涨超8%,$华领医药-B(02552)$、$东曜药业-B(01875)$涨近5%,$迈博药业-B(02181)$涨超4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02552","07226","BK1574","01477","01875","BK4614","HSCEI","BK1515","YANG","02181","BK1191","01672","BK1161","HSTECH"],"gpt_icon":0},{"id":"2518630227","title":"迈博药业-B盘中异动 下午盘股价大跌9.43%报0.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518630227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518630227?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:02","pubTimestamp":1741672972,"startTime":"0","endTime":"0","summary":"2025年03月11日下午盘14时02分,迈博药业-B股票出现异动,股价急速跳水9.43%。截至发稿,该股报0.480港元/股,成交量2000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出960港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.74%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161"],"gpt_icon":0},{"id":"2518825121","title":"迈博药业-B股价重挫18.64% 市值跌3.69亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518825121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518825121?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:01","pubTimestamp":1741572115,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘10时01分,迈博药业-B股票出现波动,股价急速跳水18.64%。截至发稿,该股报0.480港元/股,成交量2万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入9600港元,流出0港元。迈博药业-B股票所在的生物技术行业中,整体跌幅为0.97%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0},{"id":"2517972476","title":"迈博药业-B盘中异动 早盘急速上涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517972476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517972476?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:40","pubTimestamp":1741225229,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时40分,迈博药业-B股票出现异动,股价快速上涨6.06%。截至发稿,该股报0.350港元/股,成交量1.6万股,换手率0.00%,振幅0.00%。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.93%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094029963b76aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"gpt_icon":0},{"id":"2514360583","title":"迈博药业-B股价飙升10.00% 市值涨1.36亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514360583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514360583?lang=zh_cn&edition=full","pubTime":"2025-02-28 11:12","pubTimestamp":1740712358,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘11时12分,迈博药业-B股票出现波动,股价快速拉升10.00%。截至发稿,该股报0.330港元/股,成交量3万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入9900港元,流出0港元。最近的财报数据显示,该股实现营业收入1.19亿港元,净利润-1.07亿港元,每股收益-0.02港元,毛利1.03亿港元,市盈率-5.89倍。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.25%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228111238a25733b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228111238a25733b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"gpt_icon":0},{"id":"2514296738","title":"迈博药业-B盘中异动 临近收盘急速拉升5.26%报0.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514296738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514296738?lang=zh_cn&edition=full","pubTime":"2025-02-27 15:59","pubTimestamp":1740643171,"startTime":"0","endTime":"0","summary":"2025年02月27日临近收盘15时59分,迈博药业-B股票出现异动,股价大幅拉升5.26%。截至发稿,该股报0.300港元/股,成交量6万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.8万港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.31%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022715593296323ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022715593296323ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"gpt_icon":0},{"id":"2514008192","title":"迈博药业-B盘中异动 下午盘股价大跌8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514008192?lang=zh_cn&edition=full","pubTime":"2025-02-26 13:43","pubTimestamp":1740548623,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时43分,迈博药业-B股票出现异动,股价大幅下挫8.20%。截至发稿,该股报0.280港元/股,成交量4万股,换手率0.00%,振幅0.00%。迈博药业-B股票所在的生物技术行业中,整体涨幅为2.61%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613434398931b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613434398931b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0},{"id":"2512750460","title":"迈博药业-B股价重挫21.62% 市值跌2.59亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512750460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512750460?lang=zh_cn&edition=full","pubTime":"2025-02-20 13:14","pubTimestamp":1740028454,"startTime":"0","endTime":"0","summary":"2025年02月20日下午盘13时14分,迈博药业-B股票出现异动,股价快速跳水21.62%。截至发稿,该股报0.290港元/股,成交量5万股,换手率0.00%,振幅5.41%。资金方面,该股资金流入0港元,流出1.454万港元。迈博药业-B股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,歌礼制药-B、腾盛博药-B、永泰生物-B涨幅较大,振幅较大的相关个股有腾盛博药-B、昭衍新药、永泰生物-B,振幅分别为24.19%、22.98%、22.26%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220131414abd5b417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220131414abd5b417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161"],"gpt_icon":0},{"id":"2510474876","title":"迈博药业-B盘中异动 下午盘快速跳水10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510474876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510474876?lang=zh_cn&edition=full","pubTime":"2025-02-11 15:04","pubTimestamp":1739257445,"startTime":"0","endTime":"0","summary":"2025年02月11日下午盘15时04分,迈博药业-B股票出现异动,股价急速下挫10.00%。截至发稿,该股报0.270港元/股,成交量4万股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.08万港元。迈博药业-B股票所在的生物技术行业中,整体跌幅为0.80%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211150405988152e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211150405988152e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"gpt_icon":0},{"id":"2510873421","title":"迈博药业-B(02181)股价下跌10%,现价港币$0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2510873421","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510873421?lang=zh_cn&edition=full","pubTime":"2025-02-11 15:04","pubTimestamp":1739257440,"startTime":"0","endTime":"0","summary":"[下跌股]迈博药业-B(02181) 股价在下午03:04比前收市价下跌10%,现股价为港币$0.27。至目前为止,今日最高价为$0.27,而最低价为$0.27。总成交量为4万股,总成交金额为港币$1.08万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502111770/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02181","BK1574"],"gpt_icon":0},{"id":"2503312639","title":"迈博药业-B盘中异动 早盘股价大跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503312639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503312639?lang=zh_cn&edition=full","pubTime":"2025-01-13 09:50","pubTimestamp":1736733022,"startTime":"0","endTime":"0","summary":"2025年01月13日早盘09时50分,迈博药业-B股票出现波动,股价大幅下挫5.66%。截至发稿,该股报0.250港元/股,成交量10000股,换手率0.00%,振幅0.00%。迈博药业-B股票所在的生物技术行业中,整体跌幅为0.61%。迈博药业-B公司简介:迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113095023a21f7d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113095023a21f7d15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"gpt_icon":0},{"id":"2501407980","title":"迈博药业-B1月6日收盘上涨1.82%,成交4.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501407980","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501407980?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:26","pubTimestamp":1736152000,"startTime":"0","endTime":"0","summary":"1月6日,截至港股收盘,恒生指数下跌0.36%,报19688.29点。迈博药业-B收报0.28港元/股,上涨1.82%,成交量16.6万股,成交额4.62万港元,振幅1.82%。最近一个月来,迈博药业-B累计跌幅15.38%,今年来累计跌幅1.79%,跑输恒生指数-1.49%的跌幅。财务数据显示,截至2024年6月30日,迈博药业-B实现营业总收入1.08亿元,同比增长146.44%;归母净利润-9756.9万元,同比增长2.43%;毛利率86.98%,资产负债率87.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106163004985c8b87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106163004985c8b87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0},{"id":"2500291162","title":"迈博药业-B1月3日收盘下跌1.79%,成交4.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500291162","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500291162?lang=zh_cn&edition=full","pubTime":"2025-01-03 17:05","pubTimestamp":1735895153,"startTime":"0","endTime":"0","summary":"1月3日,截至港股收盘,恒生指数上涨0.7%,报19760.27点。迈博药业-B收报0.275港元/股,下跌1.79%,成交量14.8万股,成交额4.07万港元,振幅0.0%。最近一个月来,迈博药业-B累计跌幅15.38%,今年来累计跌幅1.79%,跑输恒生指数-1.49%的跌幅。财务数据显示,截至2024年6月30日,迈博药业-B实现营业总收入1.08亿元,同比增长146.44%;归母净利润-9756.9万元,同比增长2.43%;毛利率86.98%,资产负债率87.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010317085295f793fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010317085295f793fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0},{"id":"2500920436","title":"迈博药业(02181.HK)核心产品CMAB008获巴基斯坦注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2500920436","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500920436?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:02","pubTimestamp":1735830120,"startTime":"0","endTime":"0","summary":"迈博药业-B(02181.HK) 公布,核心产品之一,自主开发的重组抗肿瘤坏死因子α人鼠嵌合单克隆抗体CMAB008类停(注射用英夫利西单抗)的注册获巴基斯坦药品监管局批准,用于治疗成人溃疡性结肠炎;强直性脊柱炎;类风湿关节炎;及银屑病等。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1407544/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02181","BK1574","BK1161"],"gpt_icon":0},{"id":"2500942359","title":"迈博药业-B(02181):巴基斯坦药品监管局批准核心产品CMAB008(注射用英夫利西单抗)的注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2500942359","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500942359?lang=zh_cn&edition=full","pubTime":"2025-01-02 19:26","pubTimestamp":1735817219,"startTime":"0","endTime":"0","summary":"CMAB008类停是迈博药业于巴基斯坦获批注册的首个产品。迈博药业的产品管线目前包括多个单克隆抗体药物,除获准上市的CMAB008类停外,迈博药业开发的CMAB007奥迈舒和CMAB009恩立妥亦已获中国国家药品监督管理局的上市批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"迈博药业-B(02181):巴基斯坦药品监管局批准核心产品CMAB008(注射用英夫利西单抗)的注册","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02181","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mabpharm.cn","stockEarnings":[{"period":"1week","weight":-0.0549},{"period":"1month","weight":-0.1887},{"period":"3month","weight":0.4333},{"period":"6month","weight":0.2286},{"period":"1year","weight":0.0886},{"period":"ytd","weight":0.5357}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":-0.0082},{"period":"3month","weight":0.1003},{"period":"6month","weight":0.0816},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.1297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要产品包括奥马珠单抗(CMAB007)、西妥昔单抗(CMAB009)和英夫利昔单抗(CMAB008)等。该公司主要在中国境内经营业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.06263},{"month":2,"riseRate":0.833333,"avgChangeRate":0.076921},{"month":3,"riseRate":0.833333,"avgChangeRate":0.232854},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.090611},{"month":5,"riseRate":0.5,"avgChangeRate":-0.075154},{"month":6,"riseRate":0.666667,"avgChangeRate":0.103152},{"month":7,"riseRate":0.333333,"avgChangeRate":0.024072},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.145503},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.060445},{"month":10,"riseRate":0.5,"avgChangeRate":0.02114},{"month":11,"riseRate":0.5,"avgChangeRate":0.000751},{"month":12,"riseRate":0.5,"avgChangeRate":-0.016387}],"exchange":"SEHK","name":"迈博药业-B","nameEN":"MABPHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈博药业-B,02181,迈博药业-B股票,迈博药业-B股票老虎,迈博药业-B股票老虎国际,迈博药业-B行情,迈博药业-B股票行情,迈博药业-B股价,迈博药业-B股市,迈博药业-B股票价格,迈博药业-B股票交易,迈博药业-B股票购买,迈博药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}